Showing results (321-330 of 830) with videos related to
Sort By:
Pageof 83
Pharmacogenetics|October 1, 1996
Genetic analysis of the NAT2 and CYP2D6 polymorphisms in white patients with non-insulin-dependent diabetes mellitusJ A Agúndez, J G Menaya, R Tejeda, et al.Pharmacogenetics|January 16, 1998
CYP2D6 genotype and phenotyping by determination of dextromethorphan and metabolites in serum of healthy controls and of patients under psychotropic medicationD Köhler, S Härtter, K Fuchs, et al.Pharmacogenetics|January 16, 1998
Meta-analysis of phenotype and genotype of NAT2 deficiency in Chinese populationsH G Xie, Z H Xu, D S Ou-Yang, et al.Pharmacogenetics|March 25, 1998
Functional co-expression of CYP2D6 and human NADPH-cytochrome P450 reductase in Escherichia coliM P Pritchard, M J Glancey, J A Blake, et al.Pharmacogenetics|March 25, 1998
A rare CYP19 (aromatase) variant may increase the risk of breast cancerV N Kristensen, T I Andersen, A Lindblom, et al.Pharmacogenetics|March 25, 1998
Molecular basis of the Dark Agouti rat drug oxidation polymorphism: importance of CYP2D1 and CYP2D2Y Yamamoto, T Tasaki, A Nakamura, et al.Pharmacogenetics|November 14, 1997
Effects of thioridazine, an inhibitor of CYP2D6, on the steady-state plasma concentrations of the enantiomers of mianserin and its active metabolite, desmethylmianserin, in depressed Japanese patientsN Yasui, G Tybring, K Otani, et al.Pharmacogenetics|November 14, 1997
Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interactionK Fukuda, T Ohta, Y Oshima, et al.Pharmacogenetics|October 3, 2002
Response to infliximab treatment in Crohn's disease is not associated with mutations in the CARD15 (NOD2) gene: an analysis in 534 patients from two multicenter, prospective GCP-level trialsSilvia Mascheretti, Jochen Hampe, Peter J P Croucher, et al.Pharmacogenetics|October 3, 2002
Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's diseaseTaku Furuno, Maria-Teresa Landi, Mauro Ceroni, et al.Pageof 83